Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
Public ClinicalTrials.gov record NCT00134238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety, and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Atorvastatin Alone, in Subjects With Mixed Hyperlipidemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To look at ultrasound images taken in the carotid arteries and to look at various lipids in the blood of people with mixed hyperlipidemia
Study identification
- NCT ID
- NCT00134238
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 755 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Nov 30, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Feb 16, 2012
2003 – 2006
United States locations
- U.S. sites
- 40
- U.S. states
- 16
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Gilbert | Arizona | — | — |
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Scottsdale | Arizona | — | — |
| Pfizer Investigational Site | Alhambra | California | — | — |
| Pfizer Investigational Site | Encinitas | California | — | — |
| Pfizer Investigational Site | La Jolla | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | Hartford | Connecticut | — | — |
| Pfizer Investigational Site | Melbourne | Florida | — | — |
| Pfizer Investigational Site | Palm Bay | Florida | — | — |
| Pfizer Investigational Site | Sebastian | Florida | — | — |
| Pfizer Investigational Site | Stuart | Florida | — | — |
| Pfizer Investigational Site | Vero Beach | Florida | — | — |
| Pfizer Investigational Site | Overland Park | Kansas | — | — |
| Pfizer Investigational Site | Boston | Massachusetts | — | — |
| Pfizer Investigational Site | Cambridge | Massachusetts | — | — |
| Pfizer Investigational Site | Edina | Minnesota | — | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | Concord | New Hampshire | — | — |
| Pfizer Investigational Site | Bronxville | New York | — | — |
| Pfizer Investigational Site | Buffalo | New York | — | — |
| Pfizer Investigational Site | Mount Vernon | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | Williamsville | New York | — | — |
| Pfizer Investigational Site | Durham | North Carolina | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Salt Lake City | Utah | — | — |
| Pfizer Investigational Site | Newport News | Virginia | — | — |
| Pfizer Investigational Site | Norfolk | Virginia | — | — |
| Pfizer Investigational Site | Richmond | Virginia | — | — |
| Pfizer Investigational Site | Bothell | Washington | — | — |
| Pfizer Investigational Site | Kirkland | Washington | — | — |
| Pfizer Investigational Site | Renton | Washington | — | — |
| Pfizer Investigational Site | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00134238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2012 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00134238 live on ClinicalTrials.gov.